Navigation Links
MINRAD Receives Notice That NYSE Alternext Intends to File Delisting Application With Securities and Exchange Commission
Date:2/6/2009

n such statements. Factors that may cause actual results to differ materially from those expressed or implied by its forward-looking statements include, but are not limited to, MINRAD International's limited operating history and business development associated with being a growth stage company; its dependence on key personnel; its need to attract and retain technical and managerial personnel; its ability to execute its business strategy; the intense competition it faces; its ability to protect its intellectual property and proprietary technologies; its exposure to product liability claims resulting from the use of its products; general economic and capital market conditions; financial conditions of its customers and their perception of its financial condition relative to that of its competitors; as well as those risks described under the heading "Risk Factors" of MINRAD International's Form 10-KSB/A, filed with the Securities and Exchange Commission on April 21, 2008. Although MINRAD International, Inc. believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct.

     MINRAD International, Inc.      Contact:
     50 Cobham Drive                 Charles R. Trego, Jr.
     Orchard Park, NY 14127          Executive Vice President and CFO
                                     (716) 855-1068

'/>"/>
SOURCE MINRAD International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MINRAD International, Inc. Announces Reduction in Workforce
2. MINRAD International, Inc. to Discuss 2008 First Quarter Financial Results on Tuesday, May 13, 2008
3. MINRAD International, Inc. Announces $40.0 Million Private Placement
4. MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
5. Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the Worlds First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop
6. Fraunhofer USA Center for Molecular Biotechnology Receives Gates Foundation Grant for Avian Influenza Vaccine Development
7. AdvanDx Receives FDA 510(k) Clearance for E. coli/P. aeruginosa PNA FISH(R)
8. Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil
9. Cell Therapeutics Receives Additional NASDAQ Notification
10. Neuralstem Receives Final Notice of Allowance for New Stem Cell Immortalization Technology Patent
11. Victhom Human Bionics Neurobionix Division receives ISO 13485:2003 Certification for its Design Control System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... -- Pomerantz LLP is investigating claims on behalf of investors ... IPXL).  Such investors are advised to contact Robert ... ext. 237. The investigation concerns whether Impax ... Sections 10(b) and 20(a) of the Securities Exchange Act ... Impax Laboratories, Inc. (the "Company") issued a press release ...
(Date:7/29/2014)... July 29, 2014  Discovery Laboratories, Inc. (Nasdaq: ... a new standard of respiratory critical care, will report ... 5, 2014 before the open of the U.S. ... host a live teleconference and webcast at 9:00 a.m. ... call, Discovery Labs, management will discuss the 2014 ...
(Date:7/29/2014)... 2014  Cannabis Science, Inc. (OTC: CBIS), a ... and related consulting, applauds the Editorial Board of ... position in opposition to current federal law on ... The New York Times also announces a series ... the issue called "High Time:  An Editorial Series ...
(Date:7/29/2014)... July 29, 2014 July 29, ... pioneer in the biotechnology industry, announced that it ... Securities, Inc. to explore financing opportunities that build ... a breakthrough vaccine platform with the potential to ... company exclusively licensed the well-established LAMP platform from ...
Breaking Biology Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Impax Laboratories, Inc. - IPXL 2Discovery Labs to Report 2014 Second Quarter Financial Results and Hold Conference Call on Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 3Immunomic Therapeutics Engages Newport Coast Securities, Inc. 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 3
... second, one heartbeat. That,s what is needed for a ... the source in the heart of a dangerous cardiac arrhythmia ... beating of the heart, which, if ignored, can lead to ... yearly in the United States alone. The technique, developed ...
... the central region of ,macromolecules such as chlorophyll and ... that determines their specific function. The importance of these ... their "ease of transfer ,electrons from one region to ... Nanomaterials and Nanotechnology Research Center (a joint research center ...
... published today in the Journal of Urology, ... (degarelix) a gonadotropin-releasing hormone therapy (GnRH) for advanced ... study (CS21A) was an open-label extension of the pivotal ... was shown to be non-inferior to leuprolide in reducing ...
Cached Biology Technology:Dangerous arrhythmia analyzed in a heartbeat 2Dangerous arrhythmia analyzed in a heartbeat 3Dangerous arrhythmia analyzed in a heartbeat 4The quantum tunneling effect leads electron transport in porphyrins 2New Data on Long-Term Use of FIRMAGON® (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology 2New Data on Long-Term Use of FIRMAGON® (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology 3New Data on Long-Term Use of FIRMAGON® (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology 4New Data on Long-Term Use of FIRMAGON® (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology 5New Data on Long-Term Use of FIRMAGON® (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology 6
(Date:7/29/2014)... 29 JULY 2014 With thirty days to go ... the FEBS-EMBO 2014 Conference are well underway. The event, ... Societies (FEBS), EMBO, and the French Society for Biochemistry ... 30 August to Thursday, 4 September at the Palais ... Conference is the largest meeting for the life sciences ...
(Date:7/29/2014)... breaking new book that brings together two of the ... the profile of insect fossils through stunning photographs and ... and James E Jepson, details the incredible preservation and ... the scene for what these remarkable fossils can tell ... the future of our planet. Like the mosquito in ...
(Date:7/29/2014)... Many different types of cell, including sperm, bacteria ... as flagella. These protrusions, about one-hundredth of a ... move through fluid. Similar, shorter structures called cilia ... where they perform roles such as moving liquids ... are remarkably versatile: they transport mucus and expel ...
Breaking Biology News(10 mins):Counting down to FEBS-EMBO 2014 in Paris, France 2Unique images bring fossil insects back to life 2Microscopic rowing -- without a cox 2Microscopic rowing -- without a cox 3
... Mich.---It,s "Waterworld" snail style: Ocean-dwelling snails that spend most ... of mucus bubbles. Scientists have known about ... wondered how the rafting habit evolved. What, exactly, were ... Michigan graduate student Celia Churchill and coauthors believe they,ve ...
... Oral Squamous Cell Carcinoma (OSCC) is responsible for nearly a ... of the leading causes of cancer death - largely due ... recurrence of the disease. New research published in BioMed Central,s ... four-gene signature may accurately predict which patients are at higher ...
... at the University of California, San Diego School of Medicine ... of sugar molecule boosted disease protection in early hominids, and ... genus Homo . The findings, published in this ... National Academy of Sciences , are among the first evidence ...
Cached Biology News:In bubble-rafting snails, the eggs came first 2In bubble-rafting snails, the eggs came first 3In bubble-rafting snails, the eggs came first 4Sexual selection by sugar molecule helped determine human origins 2Sexual selection by sugar molecule helped determine human origins 3
... ion trap mass spectrometer enables high-throughput solutions ... LXQ linear ion trap mass spectrometer is ... delivering the fast cycle time and increased ... at an attractive price. The combination ...
... SYBR Safe DNA gel stain was developed specifically ... ethidium bromide for staining DNA in agarose or ... less mutagenic than ethidium bromide but SYBR Safe ... ethidium bromide. SYBR Safe stain comes as a ...
... some the things youll be telling others after ... by Erica Golemis, One look at the table ... topics in protein interaction will tell you immediately ... a part of your personal protein chemistry library. ...
... gel stain has bright fluorescence when bound to ... ideal for detecting dsDNA in gels using laser ... I nucleic gel acid stain has also ... and bandshift assays. One mL stains 100 minigels. ...
Biology Products: